Mar. 22 at 4:02 AM
$BBLG
That red area highlights the 5 milestones
 The arrows I highlighted are my key indicators on if this becomes a +
$25 stock come after the IDE
-
$MDT failed
-the guy who sold both products joined here
-so effectively they should have low cost in distribution etc
-Efficient Approval Path: Clear FDA pathway - filing planned as a device/drug combination under Pre-Market Approval (PMA) should happen
-Early-Pathway Stimulation: rhBMP induces a molecular cascade early in the pathway
-a Major is going to just wait for them to prove that they could do the
$3 billion business & buy them to tackle the
$11 -15billion dollar business
🚀
